aTYR PHARMA INCATYR
Price (close)
$0.30
Market cap
$29.9M
P/E
—
Revenue (TTM)
$190,000
Net income
-$60.8M
Dividend yield
—
1-year total return
-65.8%
Net margin
—
Revenue growth
—
Debt / equity
—
What aTYR PHARMA INC does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $10.5M | $0 | $10.4M | $353,000 | $235,000 | $190,000 |
| Net income | -$16.2M | -$33.8M | -$45.3M | -$50.4M | -$64.0M | -$74.1M |
| Free cash flow | -$15.5M | -$33.3M | -$43.5M | -$37.4M | -$69.2M | -$62.1M |
More on ATYR.
- aTYR PHARMA INC summary
- aTYR PHARMA INC financial statements
- aTYR PHARMA INC key metrics
- aTYR PHARMA INC health scores and style box
- aTYR PHARMA INC earnings
- aTYR PHARMA INC dividends
- aTYR PHARMA INC valuation
- aTYR PHARMA INC ownership and insiders
- aTYR PHARMA INC peers
Figures from aTYR PHARMA INC's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.